back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-01-05 17:12 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+25,500 vol |
33,000 | |
| Filed 2022-01-05 17:10 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+13,000 vol |
33,625 | |
| Filed 2021-03-12 16:28 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2021-03-12 16:27 Tx date 2020-03-16 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 16:27 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,875 vol |
20,625 | |
| Filed 2020-05-15 12:22 Tx date 2020-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$268.00
+400 vol $0.67 each |
1,200 | |
| Filed 2020-03-27 16:13 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,750 vol |
18,750 | |
| Filed 2020-03-27 16:11 Tx date 2020-03-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-18 09:25 Tx date 2020-03-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Demerino, Kelly
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
800 |